JPRN-jRCTs031180420已完成未知
3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation - MODEL U-SES
kozuma Ken0 个研究点目标入组 1,711 人开始时间: 2019年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,711
研究概览
简要总结
This study demonstrated that 3-month DAPT was non-inferiority to adjusted cohort of longer DAPT after BP-SES implantation in net adverse clinical events. P2Y12 inhibitor monotherapy was almost equivalent to Aspirin monotherapy after 3 months of DAPT in terms of both bleeding and thrombotic events. Direct comparison between P2Y12 inhibitor and aspirin would be necessary to confirm the efficacy and safety of P2Y12 inhibitor monotherapy after DAPT in a randomized fashion.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with coronary artery lesion who received PCI using Ultimaster Sirolimus-eluting stent.
- •-Patient considered appropriate to
- •discontinue DAPT at 3 month after stent implantation.
- •-Patients who have provided written informed consent
排除标准
- •- Patients previously experienced stent thrombosis
- •- Patients who are unable to follow up
- •- Patients who are enrolled or planned to participate in another clinical trials of antiplatelet therapy.
研究者
相似试验
Unknown
不适用
3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent ImplantationCoronary Artery DiseaseNCT02837003Teikyo University1,500
招募中
不适用
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized TrialElevated Lipoprotein(a) LevelDrug-Eluting StentDual Antiplatelet TherapyCoronary Artery DiseaseNCT06014060China National Center for Cardiovascular Diseases3,300
已完成
4 期
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 StudyCoronary Artery DiseaseNCT02619760Kyoto University, Graduate School of Medicine3,045
招募中
3 期
Outcomes of 1-month vs 3-month dual antiplatelet therapy in high bleeding risk patients after percutaneous coronary intervention, a randomized controlled trialTCTR20211024003Faculty of Medicine, Chiang Mai University502
招募中
不适用
The Study to Evaluate the Safety and Efficacy of the Onyx FamilyCoronary Artery DiseaseNCT06577896Pusan National University Yangsan Hospital500